[1]
“Anti-CD20 monoclonal antibodies in chronic lymphocytic leukaemia: Mechanisms, resistance, and the evolution of targeted immunotherapy”, Undergrad Res Health, vol. 3, no. 2, p. e3855, Nov. 2025, doi: 10.1796/.